Kawagishi Naoki 川岸直樹

Researcher Number	90849374
Other IDs
Affiliation (Current)	2025: 北海道大学, 医学研究院, 客員研究員
Affiliation (based on the past Project Information) *help	2020 – 2023: 北海道大学, 医学研究院, 客員研究員
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related
Keywords	Principal Investigator 肝線維化 / 肝癌 / HCV / バイオマーカー / 肝発がん / DAA / アンギオポイエチン２ / HCC / angiopoietin2

肝炎ウイルス制御下の肝病態進展・肝発癌機構の解明と治療応用Principal Investigator
- Principal Investigator
  
  川岸直樹
- Project Period (FY)
  2023 – 2026
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
Identification of Factors Associated with Post-SVR Hepatocellular Carcinoma and Non-Improvement of Liver Fibrosis in Hepatitis C, and Therapeutic ImplicationsPrincipal Investigator
- Principal Investigator
  
  Kawagishi Naoki
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University

All 2023 2022 2021 2020

All Journal Article

[Journal Article] Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis2023
- Author(s)
  Suda Goki、et al.,
- Journal Title
  
  Journal of Medical Virology
  
  Volume: 95 Issue: 2
- DOI
  10.1002/jmv.28452
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17008
[Journal Article] Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan2023
- Author(s)
  Sasaki Takashi、Kawagishi Naoki、et.al.,
- Journal Title
  
  Hepatology Research
  
  Volume: 53 Issue: 10 Pages: 960-967
- DOI
  10.1111/hepr.13936
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K14998, KAKENHI-PROJECT-22K08023, KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-21K07953
[Journal Article] Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma2023
- Author(s)
  Ohara Masatsugu、Suda Goki、Kohya Risako、Sasaki Takashi、Yoda Tomoka、Yoshida Sonoe、Fu Qingjie、Yang Zijian、Hosoda Shunichi、Maehara Osamu、Ohnishi Shunsuke、Tokuchi Yoshimasa、Kitagataya Takashi、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Ogawa Koji、Sakamoto Naoya
- Journal Title
  
  Frontiers in Nutrition
  
  Volume: 10 Pages: 1-10
- DOI
  10.3389/fnut.2023.1272728
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K16008, KAKENHI-PROJECT-23K14998, KAKENHI-PROJECT-23K14999, KAKENHI-PROJECT-22K08023, KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-21K07953
[Journal Article] Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C2023
- Author(s)
  Kawagishi Naoki、Suda Goki、Yamamoto Yoshiya、Baba Masaru、Furuya Ken、Maehara Osamu、Ohnishi Shunsuke、Yoshida Sonoe、Fu Qingjie、Yang Zijian、Hosoda Shunichi、Tokuchi Yoshimasa、Kitagataya Takashi、Ohara Masatsugu、Suzuki Kazuharu、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Ogawa Koji、Sakamoto Naoya
- Journal Title
  
  Viruses
  
  Volume: 15 Issue: 1 Pages: 181-181
- DOI
  10.3390/v15010181
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-23K24311
[Journal Article] Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma2023
- Author(s)
  Kohya Risako、Suda Goki、Kawagishi Naoki、et.al.,
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 12 Pages: 3257-3257
- DOI
  10.3390/cancers15123257
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K14998, KAKENHI-PROJECT-23K14999, KAKENHI-PROJECT-22K08023, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-23K24311
[Journal Article] Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight2023
- Author(s)
  Tokuchi Yoshimasa、Sho Takuya et al.,
- Journal Title
  
  Hepatology Research
  
  Volume: in press Issue: 7 Pages: 595-606
- DOI
  10.1111/hepr.13899
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-23K24311
[Journal Article] Overestimated Renal Function in Patients with Liver Cirrhosis Predicts Poor Prognosis2022
- Author(s)
  Yoshida Sonoe、Suda Goki、et al.,
- Journal Title
  
  Hepatology Research
  
  Volume: in press Issue: 7 Pages: 603-613
- DOI
  10.1111/hepr.13765
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-22K16008, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17008
[Journal Article] Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave1502022
- Author(s)
  Sho Takuya et al.,
- Journal Title
  
  Cancers
  
  Volume: 14 Issue: 16 Pages: 3938-3938
- DOI
  10.3390/cancers14163938
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17008
[Journal Article] Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy2022
- Author(s)
  Kawagishi Naoki、Suda Goki et al.,
- Journal Title
  
  Scientific Reports
  
  Volume: 12 Issue: 1
- DOI
  10.1038/s41598-022-21315-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17008
[Journal Article] Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients2022
- Author(s)
  Umemura M, Ogawa K, Morikawa K, Kubo A, Tokuchi Y, Yamada R, Kitagataya T, Shigesawa T, Shimazaki T, Kimura M, Suzuki K, Nakamura A, Ohara M, Kawagishi N, Izumi T, Nakai M, Sho T, Suda G, Natsuizaka M, Ono K, Murata K, Sugiyama M, Mizokami M, Sakamoto N
- Journal Title
  
  Hepatol Res
  
  Volume: 52 Issue: 7 Pages: 586-596
- DOI
  10.1111/hepr.13768
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K07991, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17008
[Journal Article] Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle mass2021
- Author(s)
  Tokuchi Y, Suda G, Kimura M, Maehara O, Kitagataya T, Ohara M, Yamada R, Shigesawa T, Suzuki K, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N.
- Journal Title
  
  J Viral Hepat.
  
  Volume: in press Issue: 5 Pages: 755-763
- DOI
  10.1111/jvh.13484
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17008
[Journal Article] Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria2021
- Author(s)
  Sho Takuya、Suda Goki、et al.,
- Journal Title
  
  Hepatology Research
  
  Volume: 51 Issue: 9 Pages: 979-989
- DOI
  10.1111/hepr.13693
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17008
[Journal Article] Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C2021
- Author(s)
  Kawagishi Naoki、Suda Goki、Kimura Megumi、Maehara Osamu、Yamada Ren、Tokuchi Yoshimasa、Kubo Akinori、Kitagataya Takashi、Shigesawa Taku、Suzuki Kazuharu、Ohara Masatsugu、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Kudo Yusuke、Nishida Mutsumi、Sakamoto Naoya
- Journal Title
  
  Scientific Reports
  
  Volume: 11 Issue: 1 Pages: 9207-9207
- DOI
  10.1038/s41598-021-88632-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K21592, KAKENHI-PROJECT-19H03630, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17008
[Journal Article] Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI2021
- Author(s)
  Kubo Akinori、Suda Goki、Kimura Megumi、Maehara Osamu、Tokuchi Yoshimasa、Kitagataya Takashi、Ohara Masatsugu、Yamada Ren、Shigesawa Taku、Suzuki Kazuharu、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Ohnishi Shunsuke、Sakamoto Naoya
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 14 Pages: 3633-3633
- DOI
  10.3390/cancers13143633
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-20K17039
[Journal Article] Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma2021
- Author(s)
  Shigesawa T, Suda G, Kimura M, Maehara O, Tokuchi Y, Kubo A, Yamada R, Furuya K, Baba M, Kitagataya T, Suzuki K, Ohara M, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N.
- Journal Title
  
  PLoS One
  
  Volume: 16(3) Issue: 3 Pages: e0247728-e0247728
- DOI
  10.1371/journal.pone.0247728
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-20K17039, KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K21592, KAKENHI-PROJECT-19H03630
[Journal Article] Baseline angiopoietin‐2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma2020
- Author(s)
  Shigesawa Taku、Suda Goki、Kimura Megumi、Shimazaki Tomoe、Maehara Osamu、Yamada Ren、Kitagataya Takashi、Suzuki Kazuharu、Nakamura Akihisa、Ohara Masatsugu、Umemura Machiko、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Sakamoto Naoya
- Journal Title
  
  JGH Open
  
  Volume: 4 Issue: 5 Pages: 880-888
- DOI
  10.1002/jgh3.12339
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-19H03630
[Journal Article] High serum angiopoietin‐2 level predicts non‐regression of liver stiffness measurement‐based liver fibrosis stage after direct‐acting antiviral therapy for hepatitis C2020
- Author(s)
  Kawagishi Naoki、Suda Goki、Kimura Megumi、Maehara Osamu、Shimazaki Tomoe、Yamada Ren、Kitagataya Takashi、Shigesawa Taku、Suzuki Kazuharu、Nakamura Akihisa、Ohara Masatsugu、Umemura Machiko、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Kudo Yusuke、Nishida Mutsumi、Sakamoto Naoya
- Journal Title
  
  Hepatology Research
  
  Volume: in press Issue: 6 Pages: 671-681
- DOI
  10.1111/hepr.13490
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07959, KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K21592, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-19H03630

1. KAZUMOTO Murata

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. 須田剛生

# of Collaborated Projects: 0 results

# of Collaborated Products: 9 results
3. 大原正嗣

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. 荘拓也

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
5. 坂本直哉

# of Collaborated Projects: 0 results

# of Collaborated Products: 5 results
6. 森川賢一

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
7. 夏井坂光輝

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. 小川浩司

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kawagishi Naoki 川岸 直樹

Research Projects

Research Products

Co-Researchers

肝炎ウイルス制御下の肝病態進展・肝発癌機構の解明と治療応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Identification of Factors Associated with Post-SVR Hepatocellular Carcinoma and Non-Improvement of Liver Fibrosis in Hepatitis C, and Therapeutic ImplicationsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Overestimated Renal Function in Patients with Liver Cirrhosis Predicts Poor Prognosis2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave1502022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle mass2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C2021

Author(s)

Journal Title

DOI

Kawagishi Naoki 川岸直樹